Institutional investors hold a majority ownership of ACT through the 90.12% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2014, these large investors purchased a net $34.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ATALANTA SOSNOFF MANAGEMENT LLC Bought 269.2 Thousand shares of Actavis
TEACHERS RETIREMENT SYSTEM OF TH... Bought 60.1 Thousand shares of Actavis
INVERNESS COUNSEL LLC Bought 51.5 Thousand shares of Actavis